Billy D. Chism

Array ( [id] => 6851982 [patent_doc_number] => 20030144185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Cyclic peptide structures for molecular scale electronic and photonic devices' [patent_app_type] => new [patent_app_number] => 10/143733 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10410 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144185.pdf [firstpage_image] =>[orig_patent_app_number] => 10143733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846903 [patent_doc_number] => 20030166070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human phermone polypeptides' [patent_app_type] => new [patent_app_number] => 10/142465 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35839 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166070.pdf [firstpage_image] =>[orig_patent_app_number] => 10142465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409759 [patent_doc_number] => 20040176302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Methods for inhibiting tumor cell proliferation' [patent_app_type] => new [patent_app_number] => 10/133517 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7203 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176302.pdf [firstpage_image] =>[orig_patent_app_number] => 10133517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720294 [patent_doc_number] => 20030053982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'N-terminally chemically modified protein compositions and methods' [patent_app_type] => new [patent_app_number] => 10/131956 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11634 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20030053982.pdf [firstpage_image] =>[orig_patent_app_number] => 10131956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383676 [patent_doc_number] => 06551997 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Engineered polypeptides in personal care applications' [patent_app_type] => B1 [patent_app_number] => 10/127039 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3134 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551997.pdf [firstpage_image] =>[orig_patent_app_number] => 10127039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865530 [patent_doc_number] => 20030191056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins' [patent_app_type] => new [patent_app_number] => 10/117109 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13911 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191056.pdf [firstpage_image] =>[orig_patent_app_number] => 10117109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 554375 [patent_doc_number] => 07160857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Methods for increasing schwann cell survival' [patent_app_type] => utility [patent_app_number] => 10/104709 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14499 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160857.pdf [firstpage_image] =>[orig_patent_app_number] => 10104709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951357 [patent_doc_number] => 06960561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Zinc-free and low-zinc insulin preparations having improved stability' [patent_app_type] => utility [patent_app_number] => 10/102862 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5807 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960561.pdf [firstpage_image] =>[orig_patent_app_number] => 10102862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059604 [patent_doc_number] => 06852694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Stabilized insulin formulations' [patent_app_type] => utility [patent_app_number] => 10/080034 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12712 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852694.pdf [firstpage_image] =>[orig_patent_app_number] => 10080034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005574 [patent_doc_number] => 06906171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Process for the deprotection of protected thiols' [patent_app_type] => utility [patent_app_number] => 10/052300 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3767 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906171.pdf [firstpage_image] =>[orig_patent_app_number] => 10052300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261766 [patent_doc_number] => 20020187932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Treatment of anorexia nervosa and bulimia' [patent_app_type] => new [patent_app_number] => 10/040009 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2537 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187932.pdf [firstpage_image] =>[orig_patent_app_number] => 10040009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938294 [patent_doc_number] => 06972122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Contrast enhancement agent for magnetic resonance imaging' [patent_app_type] => utility [patent_app_number] => 10/025698 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18614 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972122.pdf [firstpage_image] =>[orig_patent_app_number] => 10025698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650684 [patent_doc_number] => 20030008334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Protein nectin-3' [patent_app_type] => new [patent_app_number] => 09/959845 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5281 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008334.pdf [firstpage_image] =>[orig_patent_app_number] => 09959845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391882 [patent_doc_number] => 06544950 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury' [patent_app_type] => B1 [patent_app_number] => 10/003328 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3897 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544950.pdf [firstpage_image] =>[orig_patent_app_number] => 10003328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839292 [patent_doc_number] => 20030036632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Acetylcholinesterase-derived peptides and uses thereof' [patent_app_type] => new [patent_app_number] => 09/998042 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23024 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036632.pdf [firstpage_image] =>[orig_patent_app_number] => 09998042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417433 [patent_doc_number] => 06518246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Pharmaceutical composition and method for the treatment of neoplastic cells' [patent_app_type] => B1 [patent_app_number] => 09/994841 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 10237 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518246.pdf [firstpage_image] =>[orig_patent_app_number] => 09994841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828508 [patent_doc_number] => 20020068331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose' [patent_app_type] => new [patent_app_number] => 09/992680 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31353 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068331.pdf [firstpage_image] =>[orig_patent_app_number] => 09992680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761899 [patent_doc_number] => 20030125261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Penta- and hexapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/000007 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11445 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125261.pdf [firstpage_image] =>[orig_patent_app_number] => 10000007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761898 [patent_doc_number] => 20030125260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Tetra-and pentapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 09/999828 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8035 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125260.pdf [firstpage_image] =>[orig_patent_app_number] => 09999828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467704 [patent_doc_number] => 20040053850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Treatment of demyelinating diseases' [patent_app_type] => new [patent_app_number] => 10/398876 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9941 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053850.pdf [firstpage_image] =>[orig_patent_app_number] => 10398876 [rel_patent_id] =>[rel_patent_doc_number] =>)